although I don't get what is the total column suppose to mean, but if this is true: that rem-L is protective in the dexa-only population, and on its own has no protection against death; this has some ramifications in term of EUA or AA now or requiring another trial. Mainly, because rem-L plus dexa was not the intended treatment.
Could someone plz work out the number of patients in each group and how many died etc... I think we have been given enough detail to do so. LED has only given the percentage.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.31 |
Change
-0.100(4.15%) |
Mkt cap ! $2.956B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.35 | $2.15 | $30.94M | 13.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 75954 | $2.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.32 | 10350 | 2 |
View Market Depth
| Last trade - 16.17pm 21/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |